LGR5 and breast cancer: The differential findings regarding the manifold roles of LGR5 in ER+ vs. ER− BC might be partly explained by proliferative, estrogen-responsive Lgr5+ mammary cells [59] and a subset of dormant Lgr5+ Tetraspanin8 high (Tspan8hi) MaSC responsive to ovarian hormones [60].